Impact of Relacorilant on Blood Pressure and Antihypertensive Medication Burden in Patients With Hypercortisolism and Hypertension: Results From the GRACE Study

June 9, 2025

Moraitis et al. • 2025 • Heart in Diabetes 2025

High Medication and Cardiovascular Disease Burden in Individuals With Difficult-to-Control Type 2 Diabetes: Clinical Characteristics From the CATALYST Study

June 9, 2025

DeFronzo et al. • 2025 • Heart in Diabetes 2025

Characterization of Patients With Difficult-to-Control Type 2 Diabetes and a Post–Dexamethasone Suppression Test Cortisol of 1.2–1.8 μg/dL: Findings From a Large Prospective Study

May 15, 2025

Busch et al. • 2025 • AACE 2025 Congress

Clinical Learnings Based on a Case Series: Considerations for Identifying and Treating Hypercortisolism in Patients with Diabetes

May 15, 2025

Lucci et al. • 2025 • AACE

Open-label Extension Study Evaluating the Safety and Efficacy of Long-term Use of Relacorilant in Patients With Endogenous Hypercortisolism (Cushing Syndrome): Interim Analysis Results

May 10, 2025

Badiu et al. • 2025 • ESPE, ESE